The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Are Peptides coming off of the FDA Category 2 list? A legal breakdown Holt Law FDA mulls compounding for peptides previously flagged over safety risks BioSpace FDA takes first step in possible reversal of ban on some peptides The Washington Post